Kidney Health Evaluation Measure

CKD Intercept
The National Kidney Foundation (NKF) is collaborating with the PCPI and NCQA to develop a measure to improve chronic kidney disease (CKD) testing in people with diabetes. The intent of this process measure is to improve rates of guideline-concordant kidney health evaluation in patients with diabetes in an effort to more consistently identify and potentially treat or delay progression of CKD in this high-risk population. Annual kidney health evaluation in patients with diabetes to determine risk of CKD using estimated glomerular filtration rate (eGFR) and urine albumin creatinine ratio (UACR) is recommended by clinical practice guidelines1-3 and has been a focus of various local and national health care quality improvement initiatives, including Healthy People 20208. However, performance of these tests in patients with diabetes remains low, with rates that vary across Medicare (41.8%) and private insurers (49.0%).4
 
The description of the Kidney Health Evaluation measure may be found here
 
If you are interested in testing this measure, or would like additional information about this new measure, please contact Elizabeth Montgomery.
 
  1. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019. Diabetes Care 2019;42:S124-S38.
  2. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. American Journal of Kidney Diseases 2012;60:850-86.
  3. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Diseases 2007;49:S12-S154.
  4. Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases 2019;73:A7-A8.